Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$82.84 - $88.09 $21,538 - $22,903
-260 Reduced 4.12%
6,058 $527,000
Q4 2023

Jan 22, 2024

SELL
$69.43 - $83.43 $599,180 - $720,000
-8,630 Reduced 57.73%
6,318 $520,000
Q3 2023

Oct 17, 2023

BUY
$78.22 - $90.4 $3,519 - $4,068
45 Added 0.3%
14,948 $1.17 Million
Q2 2023

Jul 07, 2023

BUY
$79.47 - $91.38 $67,628 - $77,764
851 Added 6.06%
14,903 $1.31 Million
Q1 2023

Apr 25, 2023

BUY
$76.72 - $87.58 $610,614 - $697,049
7,959 Added 130.63%
14,052 $1.13 Million
Q3 2022

Nov 07, 2022

SELL
$80.75 - $95.31 $581,400 - $686,232
-7,200 Reduced 54.16%
6,093 $492,000
Q2 2022

Jul 27, 2022

BUY
$87.4 - $113.09 $10,662 - $13,796
122 Added 0.93%
13,293 $1.19 Million
Q1 2022

May 03, 2022

BUY
$100.58 - $112.38 $21,524 - $24,049
214 Added 1.65%
13,171 $1.46 Million
Q4 2021

Jan 20, 2022

SELL
$99.53 - $127.75 $7,663 - $9,836
-77 Reduced 0.59%
12,957 $1.34 Million
Q3 2020

Oct 16, 2020

SELL
$90.13 - $108.78 $1,351 - $1,631
-15 Reduced 0.11%
13,034 $1.35 Million
Q2 2020

Jul 16, 2020

SELL
$84.11 - $103.33 $17,663 - $21,699
-210 Reduced 1.58%
13,049 $1.2 Million
Q4 2019

Feb 12, 2020

SELL
$104.49 - $114.54 $26,749 - $29,322
-256 Reduced 1.89%
13,259 $1.5 Million
Q2 2019

Jul 22, 2019

SELL
$84.15 - $99.38 $30,294 - $35,776
-360 Reduced 2.59%
13,515 $1.32 Million
Q1 2019

Apr 23, 2019

BUY
$82.45 - $93.79 $471,366 - $536,197
5,717 Added 70.08%
13,875 $1.26 Million
Q4 2018

Feb 07, 2019

BUY
$85.8 - $99.49 $30,888 - $35,816
360 Added 4.62%
8,158 $742,000
Q2 2018

Jul 10, 2018

BUY
$77.48 - $87.83 $26,343 - $29,862
340 Added 4.56%
7,798 $668,000
Q1 2018

Apr 24, 2018

BUY
$76.55 - $87.26 $570,909 - $650,785
7,458 New
7,458 $598,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.